TY - JOUR
T1 - Effect of a primary care continuing education program on clinical practice of chronic obstructive pulmonary disease
T2 - Translating theory into practice
AU - Adams, Sandra G.
AU - Pitts, Jennifer
AU - Wynne, Jo Ellen
AU - Yawn, Barbara P.
AU - Diamond, Edward J.
AU - Lee, Shuko
AU - Dellert, Ed
AU - Hanania, Nicola A.
N1 - Funding Information:
Potential Competing Interests: Dr Adams discloses the following: investigator/grant research: National Institute of Health , Veterans Affairs Cooperative Studies Program , Bayer Pharmaceuticals Corp , Boehringer Ingelheim Pharmaceuticals Inc , Centocor Inc , GlaxoSmithKline , Novartis Pharmaceuticals AG , Pfizer Inc , and Schering-Plough Corp ; honoraria for speaking at CE programs (unrestricted grants for CE): AstraZeneca Pharmaceuticals LP , Bayer Pharmaceuticals Corp , Boehringer Ingelheim Pharmaceuticals Inc , GlaxoSmithKline , Novartis Pharmaceuticals AG , Pfizer Inc , and Schering-Plough Corp . Ms Pitts and Mr Dellert are both employees of the ACCP. Ms Wynn is employed by the AANP. Dr Yawn discloses the following: research support from Aerocrine, Boehringer Ingelheim, Forrest, GlaxoSmithKline, and Novartis. Dr Hanania discloses the following: investigator/research support from Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline, MedImmune, Novartis, Pfizer, and Sunovion; speaker bureau of Boehringer Ingelheim, GlaxoSmithKline, and Pfizer; advisory board/consultancy for Dey Inc, GlaxoSmithKline, Novartis, Pearl, and Pfizer. The programs described were conducted and sponsored by the ACCP and the AANP, which received unrestricted grants from AstraZeneca Pharmaceuticals LP , Wilmington, DE, Boehringer Ingelheim Pharmaceuticals Inc , Ridgefield, CT, and GlaxoSmithKline Pharmaceuticals Ltd , Philadelphia, PA. The funders of the unrestricted grants were not involved in the development or implementation of these programs, in the interpretation of the data, or in the preparation, review, or any part of the manuscript.
PY - 2012/9
Y1 - 2012/9
N2 - Objectives: To describe the development and implementation process and assess the effect on self-reported clinical practice changes of a multidisciplinary, collaborative, interactive continuing medical education (CME)/continuing education (CE) program on chronic obstructive pulmonary disease (COPD). Methods: Multidisciplinary subject matter experts and education specialists used a systematic instructional design approach and collaborated with the American College of Chest Physicians and American Academy of Nurse Practitioners to develop, deliver, and reproduce a 1-day interactive COPD CME/CE program for 351 primary care clinicians in 20 US cities from September 23, 2009, through November 13, 2010. Results: We recorded responses to demographic, self-confidence, and knowledge/comprehension questions by using an audience response system. Before the program, 173 of 320 participants (54.1%) had never used the Global Initiative for Chronic Obstructive Lung Disease recommendations for COPD. After the program, clinician self-confidence improved in all areas measured. In addition, participant knowledge and comprehension significantly improved (mean score, 77.1%-94.7%; P<.001). We implemented the commitment-to-change strategy in courses 6 through 20. A total of 271 of 313 participants (86.6%) completed 971 commitment-to-change statements, and 132 of 271 (48.7%) completed the follow-up survey. Of the follow-up survey respondents, 92 of 132 (69.7%) reported completely implementing at least one clinical practice change, and only 8 of 132 (6.1%) reported inability to make any clinical practice change after the program. Conclusion: A carefully designed, interactive, flexible, dynamic, and reproducible COPD CME/CE program tailored to clinicians' needs that involves diverse instructional strategies and media can have short-term and long-term improvements in clinician self-confidence, knowledge/comprehension, and clinical practice.
AB - Objectives: To describe the development and implementation process and assess the effect on self-reported clinical practice changes of a multidisciplinary, collaborative, interactive continuing medical education (CME)/continuing education (CE) program on chronic obstructive pulmonary disease (COPD). Methods: Multidisciplinary subject matter experts and education specialists used a systematic instructional design approach and collaborated with the American College of Chest Physicians and American Academy of Nurse Practitioners to develop, deliver, and reproduce a 1-day interactive COPD CME/CE program for 351 primary care clinicians in 20 US cities from September 23, 2009, through November 13, 2010. Results: We recorded responses to demographic, self-confidence, and knowledge/comprehension questions by using an audience response system. Before the program, 173 of 320 participants (54.1%) had never used the Global Initiative for Chronic Obstructive Lung Disease recommendations for COPD. After the program, clinician self-confidence improved in all areas measured. In addition, participant knowledge and comprehension significantly improved (mean score, 77.1%-94.7%; P<.001). We implemented the commitment-to-change strategy in courses 6 through 20. A total of 271 of 313 participants (86.6%) completed 971 commitment-to-change statements, and 132 of 271 (48.7%) completed the follow-up survey. Of the follow-up survey respondents, 92 of 132 (69.7%) reported completely implementing at least one clinical practice change, and only 8 of 132 (6.1%) reported inability to make any clinical practice change after the program. Conclusion: A carefully designed, interactive, flexible, dynamic, and reproducible COPD CME/CE program tailored to clinicians' needs that involves diverse instructional strategies and media can have short-term and long-term improvements in clinician self-confidence, knowledge/comprehension, and clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=84866348708&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866348708&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2012.02.028
DO - 10.1016/j.mayocp.2012.02.028
M3 - Article
C2 - 22958990
AN - SCOPUS:84866348708
SN - 0025-6196
VL - 87
SP - 862
EP - 870
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 9
ER -